Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000093

President and CEO sold 18,333 shares at an average $50.38 ($923,550)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-01 Sale : show line 1 in the form −3,304 $49.38 $163,152 2,155,063 I
2021-10-01 Sale : show line 2 in the form −10,782 $50.44 $543,844 2,144,281 I
2021-10-01 Sale : show line 3 in the form −4,247 $50.99 $216,555 2,140,034 I
Open-market sales · 18,333 sh · avg $50.38 · $923,550
Loading xslF345X03/wf-form4_163346563868452.xml…